Trial Profile
Hypercalcemia and Acute Kidney Injury Induced by Eldecalcitol in Patients with Osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 01 Nov 2019 Results assessing durability of aflibercept maintenance therapy in renovascular age-related macular degenration published in the Renal Failure
- 13 Aug 2018 New trial record